Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
If overspending hit savings, concentrate on a concrete reset plan: set a short-term goal, cut a few costs, and automate a savings transfer to recover quickly.
24,735 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A Warby Parker director recently sold 25,000 shares, triggering questions about insider moves. This article breaks do...
As an investor, timing updates can boost or trim returns. This guide breaks down whether should taiwan semiconductor ...
Insider trades by top executives can shape market perception. This guide explains what a chief medical officer sells ...
A major index reshuffle moved Apollo Global out of Russell Growth and into Russell Value. What does this mean for inv...
SpaceX is shaping up to launch its IPO, and the idea of could buying spacex stock sounds thrilling. This guide breaks...
Investors often face timing dilemmas ahead of big earnings. This guide helps you evaluate whether you should amazon s...
Thinking about selling on Amazon FBA? This practical beginner's guide covers the essentials—what FBA can do, what it ...
Bitcoin has pulled back from its peak, but history offers clues about what may come next. This practical guide breaks...
In 2022, the market dropped hard, but some dividend-focused funds held up better than the broad index. This article e...
Active fund moves can shake even steady income plays. This article breaks down why cushing asset management sells Hes...
June's trading floor is flashing mixed signals: a SpaceX-inspired rally taps telecom names, but EchoStar pulls back o...